VERA logo

Vera Therapeutics, Inc. Class A Common Stock


VERA: Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.


Show VERA Financials

Consumer Interest
SEC Filings

Recent trades of VERA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VERA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of VERA in WallStreetBets Daily Discussion


Recent insights relating to VERA

CNBC Recommendations

Recent picks made for VERA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VERA

Corporate Flights

Flights by private jets registered to VERA